Evidence map›Paper›PMID 35412939›Full record

ArticleBioengineered2022

Calcium-binding protein 39 overexpression promotes macrophages from 'M1' into 'M2' phenotype and improves chondrocyte damage in osteoarthritis by activating the AMP-activated protein kinase/sirtuin 1 axis.

Qiuliang Liu, Kai Pian, Zhen Tian, Haitao Duan, Qi Wang, Hui Zhang, Longyan Shi, Dongjian Song

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Qiuliang LiuDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
Kai PianDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
Zhen TianDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
Haitao DuanDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
Qi WangDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
Hui ZhangDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
Longyan ShiDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
Dongjian SongDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a degenerative joint disease that affects cartilage and its peripheral tissues. Up-regulation of Calcium-binding protein 39 (CAB39) has a significant protective effect on osteoblasts, but the role and related molecular mechanisms of CAB39 in OA have not yet been reported. CAB39 overexpression and knockdown models were set up in chondrocytes (ATDC5) and macrophages (RAW264.7). The OA cell model was induced in ATDC5 cells with IL-1β (10 ng/mL). Cell viability was tested by the cell counting kit-8 assay, apoptosis was checked by flow cytometry. Western blot was applied for checking the expression of MMP3, MMP13, Aggrecan, the AMPK/Sirt-1 pathway, apoptosis-related proteins (Bax, Bcl-2, and Caspase-3), and macrophage phenotypic markers (CD86, iNOS, CD206, and Arg1). An OA model was constructed in mice, and CAB39 overexpression plasmids were administered to the knee cavity of the OA model mice. As a result, CAB39 was down-regulated in IL-1β-treated chondrocytes and OA mice. Overexpressing CAB39 enhanced ATDC5 cell viability and choked IL-1β-mediated apoptosis. Overexpression of CAB39 boosted the polarization of macrophages from M1-phenotype into M2 phenotype. In addition, overexpressing CAB39 facilitated the AMPK/Sirt-1 pathway activation, and AMPK inhibitors reversed the protective effect of CAB39 overexpression on chondrocytes. Moreover, CAB39 exhibited anti-inflammatory effects in OA mice by activating the AMPK/Sirt-1 pathway. Collectively, overexpressing CAB39 heightened macrophages' M2 polarization and declined chondrocyte injury in OA by activating the AMPK/Sirt-1 pathway.

Indexed as

Calcium-Binding ProteinsChondrocytesOsteoarthritisAMP-Activated Protein KinasesAnimalsApoptosisInterleukin-1betaMacrophagesMicePhenotypeProto-Oncogene Proteins c-bcl-2Sirtuin 1AMP-Activated Protein KinasesCab39 protein, mouseCalcium-Binding ProteinsInterleukin-1betaProto-Oncogene Proteins c-bcl-2Sirtuin 1AMPKCAB39macrophagesosteoarthritissirt-1

Identifiers

PMID35412939
PMCPMC9162023
OpenAlexW4223537003

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.